tiprankstipranks
Tonix Pharma Reveals Promising TNX-801 Vaccine Data
Company Announcements

Tonix Pharma Reveals Promising TNX-801 Vaccine Data

Stay Ahead of the Market:

Tonix Pharma ( (TNXP) ) has provided an update.

Tonix Pharmaceuticals has unveiled promising data for its TNX-801 vaccine, showing it is less virulent in immune-compromised mice compared to 20th-century vaccinia vaccines. This breakthrough suggests TNX-801 could be an effective candidate in controlling mpox spread. Investors should note the company’s forward-looking statements about product development and potential growth, while being mindful of inherent market risks.

Find detailed analytics on TNXP stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles